The Indian Patent Office has rejected Abbott’s application for an HIV drug patent, finding no inventive step in the claimed composition. This decision highlights the robust scrutiny applied to pharmaceutical patents in India and the importance of pre grant opposition in safeguarding public health interests.
Read more about Abbott’s HIV Drug Patent “Not an Invention”Category: Patents
Patent and Design statistics in India : Recap 2018
This post presents an analytical overview of patent and design statistics in India for 2018. It highlights changes in publications, grants, examinations, and city-wise distributions, offering a factual comparison with the previous year.
Read more about Patent and Design statistics in India : Recap 2018Indian Patent Statistics, Interesting inventions, Patent Agent Examination Final Results, IIPLA conference, BananaIP updates, Patent Infringement news and more
This post presents an analysis of Indian patent statistics, notable inventions, and patent agent examination results. It further covers major IP conferences and recent patent infringement news, compiled by BananaIP Counsels.
Read more about Indian Patent Statistics, Interesting inventions, Patent Agent Examination Final Results, IIPLA conference, BananaIP updates, Patent Infringement news and moreIndian Patent Statistics, Interesting inventions, Monsanto patent case, AMD versus Mediatek, USPTO news, International patent news and more
This report analyses recent trends in Indian patent statistics, important inventions, and major legal developments such as the Monsanto patent case and AMD versus Mediatek. It also updates on new government policies and significant international patent news, maintaining an objective and factual perspective.
Read more about Indian Patent Statistics, Interesting inventions, Monsanto patent case, AMD versus Mediatek, USPTO news, International patent news and moreIndian Patent Statistics, Interesting inventions, Comprehensive e-filing system for Design filing, Apple v. WiLAN, Qualcomm v. Apple in Germany, USPTO issues revised subject matter eligibility guidance
The post analyses Indian patent statistics and recent innovations, with updates on design e-filing and international patent disputes. It also covers revised USPTO eligibility guidance and EPO appointments, offering a structured legal perspective.
Read more about Indian Patent Statistics, Interesting inventions, Comprehensive e-filing system for Design filing, Apple v. WiLAN, Qualcomm v. Apple in Germany, USPTO issues revised subject matter eligibility guidanceAdding Salt Water to Fire Automobiles
This post explores the accidental invention of using salt water as a fuel source through radio frequency technology. It also reviews historical patents on alternative fuel systems, highlighting the significance of such innovations for the automotive sector.
Read more about Adding Salt Water to Fire AutomobilesDriving on Hydrogen
This article examines Tata Motors’ research on hydrogen as an automotive fuel amid dwindling fossil resources. It reviews a key patent and explains the technology and legal context surrounding hydrogen-powered vehicles.
Read more about Driving on HydrogenPatent Damages: How Much is Too Much?
The Uniloc v Microsoft case has reignited the debate on calculating patent damages, with the US Federal Circuit rejecting the 25 percent rule as a basis for reasonable royalty. This decision is likely to shape future patent infringement litigation both in the US and globally.
Read more about Patent Damages: How Much is Too Much?An Incentive to Green Technology Patent Applications
This post analyses the incentives for green technology patent applications, focusing on accelerated examination programmes in the US. It highlights the necessity for similar initiatives in India to promote innovation and timely market access for green technologies.
Read more about An Incentive to Green Technology Patent ApplicationsPatentability of Biotech Inventions in USA – Patentable Subject Matter
This post provides an analytical overview of the patentability of biotech inventions in the USA, focusing on statutory exclusions and major judicial decisions. It explains how US courts interpret the product of nature doctrine and outlines current limitations and developments in biotechnology patent law.
Read more about Patentability of Biotech Inventions in USA – Patentable Subject Matter